Given the important function of SOX9 in regulating cancer stem cells (29), it is plausible that initial ADT/ARSi treatment induces AR-V7 expression, which subsequently activates SOX9 to maintain metastatic cancer stem cells, possessing both stem cell properties and invasive capabilities that contribute to cancer metastasis. The gene discussed is SOX9; the disease is cancer.